The indirect fluorescent-antibody (IFA) method for diagnosis of toxoplasmosis is widely used and is considered to be as specific as the Sabin-Feldman dye test. After observing a patient with systemic lupus erythematosus (SLE) who had a positive toxoplasma IFA test but a negative dye test, we studied sera with high titers of antinuclear antibodies from 16 SLE patients andfrom 2 with rheumatoid arthritis for Toxoplasma antibodies in the immunoglobulin G and M (IgG and IgM) IFA tests and the dye test. Results of these tests were compared with titers of antinuclear antibodies, precipitating antibodies to single-strand deoxyribonucleic acid (DNA), and binding antibodies by use of DNA labeled with 3H-actinomycin D. Of 18 patients, 11 had IgG and 4 had IgM IFA Toxoplasma antibodies; only 2 had antibodies detectable in the dye test. The immunofluorescence patterns in the Toxoplasma IFA test were indistinguishable from those obtained in patients with toxoplasmosis without antinuclear antibodies. Absorption of SLE sera with DNA did not result in a decrease in Toxoplasma IFA titers. When SLE sera were absorbed with live T. gondii, a marked drop in IgG IFA titer was observed as well as a decrease in titers of antinuclear antibodies and 3H-DNA binding. Treatment of Toxoplasma cells with deoxyribonuclease and ribonuclease did not decrease their fluorescence. These results suggest that T. gondii nuclear antigens can absorb antinuclear antibodies but do not have exposed substrates for deoxyribonuclease. Tests in which organisms containing "nuclear" antigens for IFA detection of antibodies to these organisms are used may result in "false-positives" with sera containing antinuclear antibodies.
The indirect fluorescent-antibody (IFA) method for diagnosis of toxoplasmosis is widely used and is considered to be as specific as the Sabin-Feldman dye test. After observing a patient with systemic lupus erythematosus (SLE) who had a positive toxoplasma IFA test but a negative dye test, we studied sera with high titers of antinuclear antibodies from 16 SLE patients andfrom 2 with rheumatoid arthritis for Toxoplasma antibodies in the immunoglobulin G and M (IgG and IgM) IFA tests and the dye test. Results of these tests were compared with titers of antinuclear antibodies, precipitating antibodies to single-strand deoxyribonucleic acid (DNA), and binding antibodies by use of DNA labeled with 3H-actinomycin D. Of 18 patients, 11 had IgG and 4 had IgM IFA Toxoplasma antibodies; only 2 had antibodies detectable in the dye test. The immunofluorescence patterns in the Toxoplasma IFA test were indistinguishable from those obtained in patients with toxoplasmosis without antinuclear antibodies. Absorption of SLE sera with DNA did not result in a decrease in Toxoplasma IFA titers. When SLE sera were absorbed with live T. gondii, a marked drop in IgG IFA titer was observed as well as a decrease in titers of antinuclear antibodies and 3H-DNA binding. Treatment of Toxoplasma cells with deoxyribonuclease and ribonuclease did not decrease their fluorescence. These results suggest that T. gondii nuclear antigens can absorb antinuclear antibodies but do not have exposed substrates for deoxyribonuclease. Tests in which organisms containing "nuclear" antigens for IFA detection of antibodies to these organisms are used may result in "false-positives" with sera containing antinuclear antibodies.
The most specific and carefully studied and controlled serological test for toxoplasmosis is the Sabin-Feldman dye test (11) . Because it requires human accessory factor (4), often difficult to obtain, and the use of live parasites, much attention has been turned toward the development of alternative diagnostic tests. One of the most significant developments for the serological diagnosis of toxoplasmosis is the adaptation of the indirect fluorescent-antibody (IFA) method which does not require living organisms or accessory factor. Application of this method to the diagnosis of toxoplasmosis has occurred throughout the world, and in general there is excellent agreement as to positivity and negativity when compared with complement-fixation, hemagglutination, and dye tests (8) (13) .
The IFA technique has recently been adapted for the demonstration of immunoglobulin M (IgM) Toxoplasma antibodies and has proved useful in establishing the diagnosis of acute congenital and acquired infection (9, 10) .
The IFA test for toxoplasmosis has been considered absolutely specific, and, because it is very simple to perform, it is being used by many laboratories, rather than the Sabin-Feldman dye test, for routine Toxoplasma serology. The present study was prompted by the serological test results obtained in the patient described below.
This patient with systemic lupus erythematosus (SLE) had the unusual finding of a positive IFA test and a negative dye test. This suggested that certain patients with SLE might have "falsepositive" reactions in the IFA test on the basis of their antinuclear antibodies rather than on the basis of previous infection with Toxoplasma. sive weakness, malaise, and a 6.8 kg weight loss. Two weeks prior to admission, he complained of anorexia and sore throat and had documented afternoon and evening fever to 103 F (39.4 C). Two days prior to admission, he noted swelling, pain, and a pruritic skin rash over both lower legs and ankles. Past history included severe measles at the age of 5 years, with subsequent partial bilateral hearing loss. There was no history of allergy, and he took no medication other than occasional aspirin.
Pertinent physical findings were an oral temperature of 101 F (38.3 C), partial hearing loss bilaterally, and enlarged nontender lymph nodes in cervical, axillary, epitrochlear, and inguinal regions. There was mild edema, tenderness, and a discrete macular rash over the anterior tibial area bilaterally. against single-strand calf thymus deoxyribonucleic acid (DNA; Worthington Biochemical Corp., Freehold, N.J.) were performed as previously described (5) . Tests to detect binding antibody by the modification of the Farr technique, in which native calf thymus DNA labeled with 3H-actinomycin D in a concentration of 20 ,ug/ml is used, were performed as described by Carr et al. (3) with the modification that normal human serum was used as diluent.
More than 20% binding of the labeled DNA is considered abnormal. Values expressed in Table 1 for DNA 3H binding indicate the fractional increase in binding of the patient's serum tested over normal sera tested on the same day; e.g., a value of 0.5 indicates that the patient's serum bound 30% of the labeled DNA, and the maximal binding of five normal sera on that day was 20%.
The Sabin-Feldman dye test and the IgG and IgM IFA tests for Toxoplasma antibodies were performed as described previously (9) . To read the IFA tests, a dark-field condenser with filters BG 12 and no. 50 Zeiss and an HBO200 Osram lamp as the ultraviolet source were used, rather than a bright-field condenser, to gain better definition of the staining of Toxoplasma cell walls. All titers are expressed as final dilutions of serum. The initial serum dilution was undiluted (1:2 final dilution) in the dye test, 1:4 in the IgG IFA test, and 1:10 in the IgM IFA test.
Sera were absorbed with preparations of DNA containing 100 or 500 ,ug of calf thymus DNA per ml. DNA was dissolved in distilled water and denatured by heating in a water bath at 100 C for 10 min, followed immediately by cooling in an ice bath. Equal volumes of these DNA preparations and test serum were mixed, allowed to incubate for at least 10 min at room temperature, and then tested in the IgG Toxoplasma IFA test.
Absorption of sera with live T. gondii of the RH strain was achieved by diluting the patient's serum 1: 5 in phosphate-buffered saline, pH 7.1 (PBS), and mixing 0.2 ml of this dilution with approximately 6 X 108 live Toxoplasma cells obtained from the peritoneal cavity of Swiss-Webster mice which had been infected 3 days earlier. The peritoneal exudate was first centrifuged at 400 X g for 20 min; the supernatant fluid was discarded, and the sediment was resuspended and washed three times with PBS. Sera were inactivated at 56 C for 30 min before absorption. The absorption was carried out at 4 C for 24 hr with constant rotation by use of a Fischer Roto-Rack. The organisms were then removed by centrifugation at 400 X g for 20 min at 4 C. A serum with titers in the dye and IgG IFA tests of 1:1,024 was absorbed as a positive control. 
